r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

TW

Troy Edward Wilson

Insider · President and CEO · KURA

Troy Edward Wilson files insider transactions with the SEC as a president and ceo of Kura Oncology (KURA). We hold 3 disclosed purchases and sales filed since 21 October 2013, 3 of them in the last 90 days.

  • Files forKURA
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure24 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 29 January 2016 — 24 August 2026President and CEO · Kura Oncology (KURA)101 Form 4 lines · source: SEC Form 4
  • Filed 18 October 2013 — 12 June 2026Director · Puma Biotechnology (PBYI)23 Form 4 lines · source: SEC Form 4
  • Filed 16 June 2020 — 27 February 2026Director · Avidity Biosciences (RNA)32 Form 4 lines · source: SEC Form 4
  • Filed 27 February 2026 — 27 February 2026Director · Avidity Biosciences (RNAM)10 Form 4 lines · source: SEC Form 4
  • Filed 1 April 2015 — 2 January 2019Director · Zosano Pharma (ZSAN)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.